Multiple Sclerosis and Neuromyletis Optica - Clinical Trials
The UC Davis Neurology Department’s faculty members and research staff conduct both basic and clinical research aimed at developing new treatments for Multiple Sclerosis (MS) and Neuromyelitis Optica (NMO).
The participation of our study volunteers in controlled clinical trials has enabled our researchers to help develop new drugs that show promise as future treatments for MS. Patients who would like to assist our ongoing research efforts may be able to participate in clinical trials designed to test these as well as other new therapies for MS and NMO.
Open Studies Currently Enrolling Participants at UC Davis
MedDay – Effect of MD1003 in Progressive MS (SP12) (SP12)
If you are interested in participating or want more information on our clinical trials, please contact:
Janelle Butters, RN, at (916) 734-6276, firstname.lastname@example.org